Intrinsic Value
Halozyme Therapeutics, Inc. (HALO)
$41.21
+0.35 (+0.86%)
Enterprise Value | 16,790.57 |
---|---|
Net Debt | 1,380.88 |
Equity Value | 15,409.69 |
Shares Outstanding | 134.20 |
Equity Value Per Share | 114.83 |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt